Stay updated on Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page; the Study Details content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:06:31.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Summary: The page adds a government funding status notice and opens new operating-status references, and updates the revision version to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:37:39.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T11:17:09.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.
    Difference
    0.2%
    Check dated 2025-09-14T00:52:12.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T21:27:23.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Pazopanib and additional details about a clinical trial involving Nivolumab, while also removing some previous drug information and location details.
    Difference
    7%
    Check dated 2025-08-30T15:57:24.000Z thumbnail image

Stay in the know with updates to Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.